Fred Lublin

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Bernhard Hemmer, Ludwig Kappos, Stephen L. Hauser, 2017, The New England journal of medicine.

The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability

Gary R Cutter, Paul M Matthews, Peter Feys, 2017, Multiple sclerosis.

Recommendations from the national multiple sclerosis society clinical outcomes assessment task force

Christian Confavreux, John Petkau, Karl Syndulko, 1997, Annals of neurology.

Novel Agents for Relapsing Forms of Multiple Sclerosis.

F. Lublin, Fred Lublin, A. Harel, 2016, Annual review of medicine.

Clinical outcomes assessment in multiple sclerosis

Christian Confavreux, Alan Thompson, Stephen M. Rao, 1996, Annals of neurology.

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

Ludwig Kappos, Xavier Montalban, David H. Miller, 2016, The Lancet.

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

Bernhard Hemmer, Ludwig Kappos, Maria Assunta Rocca, 2019, The Lancet Neurology.

Multiple sclerosis trial designs for the 21st century: Building on recent lessons

F. Lublin, Fred Lublin, 2005, Journal of neurology.